Invesco Ltd. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$63,161,000
+4.5%
1,363,314
-45.0%
0.02%
-20.0%
Q1 2019$60,435,000
+48.1%
2,478,886
-13.4%
0.02%
+25.0%
Q4 2018$40,798,000
-24.1%
2,863,024
-19.1%
0.02%
-5.9%
Q3 2018$53,777,000
-15.2%
3,538,029
-6.4%
0.02%
-19.0%
Q2 2018$63,408,000
+25.6%
3,778,747
+22.1%
0.02%
+10.5%
Q1 2018$50,490,000
+7.7%
3,093,830
-15.5%
0.02%
+11.8%
Q4 2017$46,878,000
+71.2%
3,662,296
+64.5%
0.02%
+70.0%
Q3 2017$27,379,000
+72.8%
2,226,002
+17.6%
0.01%
+100.0%
Q2 2017$15,842,000
-39.9%
1,892,728
-35.8%
0.01%
-44.4%
Q1 2017$26,364,000
+55.8%
2,949,039
+53.2%
0.01%
+50.0%
Q4 2016$16,922,000
+30.2%
1,925,148
-0.0%
0.01%
+50.0%
Q3 2016$12,998,000
+23.7%
1,925,674
-16.5%
0.00%0.0%
Q3 2015$10,511,000
-24.5%
2,305,104
+19.4%
0.00%
-20.0%
Q2 2015$13,919,000
+4.2%
1,930,539
+6.5%
0.01%0.0%
Q1 2015$13,363,000
+6788.1%
1,813,209
+4587.2%
0.01%
Q4 2013$194,000
-94.3%
38,684
-93.0%
0.00%
-100.0%
Q3 2013$3,424,000
+38.0%
550,468
+0.7%
0.00%0.0%
Q2 2013$2,481,000546,4430.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 17,850,650$75,330,0005.64%
BVF INC/IL 6,682,711$28,201,0004.81%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,729,361$36,838,0001.49%
First Light Asset Management, LLC 530,391$2,238,0000.94%
KOPP INVESTMENT ADVISORS LLC 376,477$1,589,0000.78%
Sarissa Capital Management LP 700,000$2,954,0000.57%
Orbimed Advisors 10,689,000$45,108,0000.41%
Bedell Frazier Investment Counselling, LLC 178,971$755,0000.37%
PINNACLE ASSOCIATES LTD 3,453,487$14,574,0000.31%
Artal Group S.A. 3,710,000$15,656,0000.29%
View complete list of ARRAY BIOPHARMA INC shareholders